Turning Point Reports 29% Sales Growth in Q4 Amid Earnings Dip
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy TPB?
Source: NASDAQ.COM
- Significant Sales Growth: Turning Point's sales increased by 29% in Q4, while adjusted earnings per share dipped by 3%, surpassing Wall Street expectations and indicating strong market demand during the company's transition.
- Surge in Nicotine Pouch Sales: Nicotine pouch sales soared by 266% in Q4, accounting for 34% of total sales, up from just 12% last year, demonstrating the company's successful expansion of its distribution network and potential as a primary revenue source.
- Rising Costs Impact Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and leading to a decline in profitability, reflecting the cost pressures faced during the transition.
- Optimistic Market Outlook: Although shares fell by 20%, the market remains cautiously optimistic about Turning Point's future, with the nicotine pouch market projected to grow by at least 20% over the next five years, as the company actively adjusts its strategy to align with this trend.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TPB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TPB
Wall Street analysts forecast TPB stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 107.570
Low
110.00
Averages
116.67
High
120.00
Current: 107.570
Low
110.00
Averages
116.67
High
120.00
About TPB
Turning Point Brands, Inc. is a manufacturer, marketer and distributor of branded consumer products. It sells a range of products to adult consumers, consisting of staple products under the brands Zig-Zag and Stoker’s. Its segments include Zig-Zag Products (Zig-Zag) and Stoker’s Products (Stoker’s). Zig-Zag principally markets and distributes rolling papers, tubes, and related products; finished cigars and make-your-own cigar wraps, and other accessories. It introduced Zig-Zag ‘Rillo-sized wraps, which are similar in size to cigarillos, a type of machine-made cigars. Stoker’s manufactures and markets moist snuff tobacco (MST) and contract for and market FRE, its modern oral product and contract for and market loose-leaf chewing tobacco products. Its products are available in approximately 200,000 in the United States retail locations which, with the addition of retail stores in Canada, brings its total North American retail presence to an estimated 220,000 points of distribution.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
See More
Turning Point Brands Stock Enters Oversold Territory
- Oversold Indicator Analysis: Turning Point Brands Inc's Relative Strength Index (RSI) has dropped to 27.5, below the oversold threshold of 30, indicating that the recent heavy selling may be nearing exhaustion, thus providing potential buying opportunities for investors.
- Dividend Yield Opportunity: With the current share price at $107.57, TPB's annualized dividend of $0.32 translates to an annual yield of 0.30%, allowing dividend investors to capture a higher yield amidst falling prices, which attracts more investor interest.
- Market Comparison Analysis: Compared to the average RSI of 50.3 for other dividend stocks covered by Dividend Channel, TPB's significantly lower RSI suggests relative weakness in the market, potentially appealing to investors seeking undervalued stocks.
- Dividend History Consideration: Although dividends are not always predictable, analyzing TPB's dividend history can help investors assess whether the recent dividend is likely to continue, thereby influencing their investment decisions.
See More
Cannell Capital Sells Turning Point Brands Shares in Q4
- Share Sale Details: Cannell Capital sold 128,224 shares of Turning Point Brands in Q4 2025, with an estimated transaction value of $12.54 million based on the average stock price for the quarter, indicating a strategic move to realize gains.
- Decline in Position Value: The fund's quarter-end position value decreased by $12.18 million, reflecting both the impact of share sales and fluctuations in stock price, which highlights the volatility in the market.
- Company Performance Overview: Turning Point Brands reported approximately $463 million in net sales for 2025, a 28% increase, with net income of $58 million and adjusted EBITDA around $119.5 million, demonstrating strong earnings power from its core brands.
- Market Performance Analysis: Although Cannell Capital trimmed its stake to less than 3% of assets, Turning Point Brands' stock has risen 53% over the past year, indicating robust demand and margin expansion across convenience channels.
See More
Cannell Capital Sells Shares of Turning Point Brands
- Share Sale Overview: Cannell Capital reported the sale of 128,224 shares of Turning Point Brands in its February 17, 2026 SEC filing, with an estimated transaction value of $12.54 million, reflecting the company's strong performance in Q4 2025.
- Asset Management Impact: Following the sale, Turning Point Brands now constitutes 2.73% of Cannell Capital's 13F reportable AUM, while the fund's quarter-end position dropped by $12.18 million, indicating the impact of market fluctuations on its portfolio.
- Company Performance Highlights: Turning Point Brands achieved net sales of approximately $463 million in 2025, a 28% increase year-over-year, with net income of $58 million, showcasing strong cash flow in the rolling papers and alternative tobacco products sector.
- Investor Outlook Analysis: This share sale may represent Cannell Capital's strategy to lock in gains after a strong performance, and while reducing the position to below 3% does not imply abandonment of the long-term view, future growth will depend on brand durability and pricing power.
See More
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and creating market opportunities for companies like Doseology.
- Product Innovation Launch: Doseology has launched its 'Feed That Brain' energy pouches in the U.S., marking its first direct-to-consumer initiative aimed at providing sugar-free, smoke-free energy supplements that align with modern consumer preferences for health and convenience.
- Strategic Milestone: This U.S. pilot project represents a significant step for Doseology in validating oral pouch delivery as a scalable stimulant platform, with plans to evaluate consumer adoption and repeat purchase behavior, particularly targeting the demand for alternatives to traditional energy drinks.
- Leadership Change: Doseology recently appointed Larry Latowsky as Executive Chairman, whose experience from Katz Group Canada is expected to provide strategic guidance, enhance team confidence, and drive the release of long-term value.
See More
Turning Point Brands Stock Enters Oversold Territory
- Oversold Indicator Analysis: Turning Point Brands Inc's Relative Strength Index (RSI) has dropped to 27.5, below the oversold threshold of 30, indicating that the recent heavy selling may be nearing exhaustion, thus providing potential buying opportunities for investors.
- Dividend Yield Opportunity: With the current share price at $107.57, TPB's annualized dividend of $0.32 translates to an annual yield of 0.30%, allowing dividend investors to capture a higher yield amidst falling prices, which attracts more investor interest.
- Market Comparison Analysis: Compared to the average RSI of 50.3 for other dividend stocks covered by Dividend Channel, TPB's significantly lower RSI suggests relative weakness in the market, potentially appealing to investors seeking undervalued stocks.
- Dividend History Consideration: Although dividends are not always predictable, analyzing TPB's dividend history can help investors assess whether the recent dividend is likely to continue, thereby influencing their investment decisions.
See More
Cannell Capital Sells Turning Point Brands Shares in Q4
- Share Sale Details: Cannell Capital sold 128,224 shares of Turning Point Brands in Q4 2025, with an estimated transaction value of $12.54 million based on the average stock price for the quarter, indicating a strategic move to realize gains.
- Decline in Position Value: The fund's quarter-end position value decreased by $12.18 million, reflecting both the impact of share sales and fluctuations in stock price, which highlights the volatility in the market.
- Company Performance Overview: Turning Point Brands reported approximately $463 million in net sales for 2025, a 28% increase, with net income of $58 million and adjusted EBITDA around $119.5 million, demonstrating strong earnings power from its core brands.
- Market Performance Analysis: Although Cannell Capital trimmed its stake to less than 3% of assets, Turning Point Brands' stock has risen 53% over the past year, indicating robust demand and margin expansion across convenience channels.
See More
Cannell Capital Sells Shares of Turning Point Brands
- Share Sale Overview: Cannell Capital reported the sale of 128,224 shares of Turning Point Brands in its February 17, 2026 SEC filing, with an estimated transaction value of $12.54 million, reflecting the company's strong performance in Q4 2025.
- Asset Management Impact: Following the sale, Turning Point Brands now constitutes 2.73% of Cannell Capital's 13F reportable AUM, while the fund's quarter-end position dropped by $12.18 million, indicating the impact of market fluctuations on its portfolio.
- Company Performance Highlights: Turning Point Brands achieved net sales of approximately $463 million in 2025, a 28% increase year-over-year, with net income of $58 million, showcasing strong cash flow in the rolling papers and alternative tobacco products sector.
- Investor Outlook Analysis: This share sale may represent Cannell Capital's strategy to lock in gains after a strong performance, and while reducing the position to below 3% does not imply abandonment of the long-term view, future growth will depend on brand durability and pricing power.
See More
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
